William R. Ringo

Insider Reports History

Entity
Individual
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William R. Ringo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. Director Common Stock 23.4K $19.9K $0.85 Jul 10, 2023 Direct
Sensei Biotherapeutics, Inc. Director Stock Option (Right to Buy) 19K Jun 11, 2024 Direct
ASSEMBLY BIOSCIENCES, INC. Director Stock Option (right to buy) 2.75K May 29, 2024 Direct

Insider Reports Filed by William R. Ringo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNSE Sensei Biotherapeutics, Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
ASMB ASSEMBLY BIOSCIENCES, INC. May 29, 2024 1 $0 4 May 30, 2024 Director
SNSE Sensei Biotherapeutics, Inc. Jul 10, 2023 2 $0 4 Jul 12, 2023 Director
ASMB ASSEMBLY BIOSCIENCES, INC. May 25, 2023 1 $0 4 May 30, 2023 Director
ASMB ASSEMBLY BIOSCIENCES, INC. May 25, 2022 1 $0 4 May 27, 2022 Director
SNSE Sensei Biotherapeutics, Inc. Mar 8, 2022 3 $0 4 Mar 9, 2022 Director
SNSE Sensei Biotherapeutics, Inc. Mar 8, 2022 0 $0 3 Mar 9, 2022 Director
ASMB ASSEMBLY BIOSCIENCES, INC. May 20, 2021 1 $0 4 May 24, 2021 Director